A study at Massachusetts General Hospital found that clinical decision support software could prevent 95% of medication errors in the operating room, highlighting its potential to enhance patient safety.

Tempus AI, leveraging one of the world’s largest clinical and molecular oncology data libraries, files for an IPO, aiming to raise substantial funds to support its mission of advancing AI-powered precision medicine.

Telemedicine significantly enhances patient access to care by offering a wide range of services from general health to specialized treatments, all at potentially lower costs compared to traditional visits.

A recent randomized trial demonstrated that intravenous amino acid infusions can significantly reduce the incidence of acute kidney injury in patients undergoing cardiac surgery, highlighting a potential new approach to mitigating this common complication.

A phase 2 trial found that tirzepatide, administered once weekly, significantly improved the resolution of MASH and fibrosis stages in patients with moderate to severe liver fibrosis. These results highlight tirzepatide’s potential as a treatment option, emphasizing the need for further research to validate these findings in larger, long-term studies.

The randomized, controlled trial demonstrates that early intervention by pulmonologists for undiagnosed COPD and asthma results in lower health care utilization and improved patient outcomes, compared to usual primary care.